Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TRV vs GSK✓SelectedUSD · GSKTRV vs GSK performance historyLatest closeAs of+0.67%11/20
Stock and ETF performance explorer

TRV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+140.4%
GSK return
+53.4%
Excess return
+87.1%
Maximum drawdown
-12.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-0.1%+0.8%+0.7%
7D-2.5%-5.3%+2.9%-1.3%
30D-1.4%-3.7%+2.2%-0.7%
3M+8.3%-7.3%+15.5%+9.8%
6M+29.1%-4.2%+33.3%+30.0%
YTD+37.1%+0.9%+36.2%+36.6%
1Y+38.7%+7.3%+31.4%+36.7%
3Y+140.4%+52.7%+87.7%+122.5%
All+140.4%+53.4%+87.1%+122.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling